OpenAI Buys Orchestra Bio to Put AI Agents in Charge of Drug Development Grunt Work
The ChatGPT maker is folding Orchestra’s drug-program agents into Rosalind, its life sciences suite, betting AI can shave time off the decade-plus it takes to bring a medicine to patients.
- Fuente
- Decrypt
- Publicado
- 2026-10-20 21:46 UTC
- Cache actualizado
- 2026-10-20 21:56 UTC
Esta página solo muestra el título, el resumen y los datos de la fuente.
Abrir original ↗Comprobar comisiones